DK0625903T3 - Topiske antiglaukompræparater omfattende carbonsyreanhydraseinhibitorer og beta-blokkere - Google Patents

Topiske antiglaukompræparater omfattende carbonsyreanhydraseinhibitorer og beta-blokkere

Info

Publication number
DK0625903T3
DK0625903T3 DK93906084T DK93906084T DK0625903T3 DK 0625903 T3 DK0625903 T3 DK 0625903T3 DK 93906084 T DK93906084 T DK 93906084T DK 93906084 T DK93906084 T DK 93906084T DK 0625903 T3 DK0625903 T3 DK 0625903T3
Authority
DK
Denmark
Prior art keywords
beta
blockers
carboxylic acid
compositions
glaucoma
Prior art date
Application number
DK93906084T
Other languages
English (en)
Inventor
Thomas Robert Dean
Louis Desantis Jr
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Application granted granted Critical
Publication of DK0625903T3 publication Critical patent/DK0625903T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK93906084T 1992-02-21 1993-02-19 Topiske antiglaukompræparater omfattende carbonsyreanhydraseinhibitorer og beta-blokkere DK0625903T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83986992A 1992-02-21 1992-02-21
PCT/US1993/001487 WO1993016701A2 (en) 1992-02-21 1993-02-19 Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers

Publications (1)

Publication Number Publication Date
DK0625903T3 true DK0625903T3 (da) 1999-05-10

Family

ID=25280847

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93906084T DK0625903T3 (da) 1992-02-21 1993-02-19 Topiske antiglaukompræparater omfattende carbonsyreanhydraseinhibitorer og beta-blokkere

Country Status (9)

Country Link
EP (1) EP0625903B1 (da)
JP (2) JP2965267B2 (da)
AT (1) ATE169499T1 (da)
AU (1) AU677577B2 (da)
CA (1) CA2129037C (da)
DE (1) DE69320329T2 (da)
DK (1) DK0625903T3 (da)
ES (1) ES2118941T3 (da)
WO (1) WO1993016701A2 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG84487A1 (en) 1991-04-17 2001-11-20 Merck & Co Inc Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a b-adrenergic antagonist
US6316443B1 (en) 1994-08-04 2001-11-13 Merck & Co., Inc. Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a β-adrenergic antagonist
US6071904A (en) * 1996-12-11 2000-06-06 Alcon Laboratories, Inc. Process for manufacturing ophthalmic suspensions
EP1024810A4 (en) * 1997-06-26 2003-06-11 Merck & Co Inc METHOD FOR OPTIMIZING RETINAL AND THE HEALTH OF THE OPTICAL NERVE
WO1999037292A2 (en) * 1998-01-23 1999-07-29 Merck Sharp & Dohme B.V. Carbonic anhydrase inhibitor for increasing oxygen tension in the optic nerve and retina
AU5251999A (en) 1998-08-04 2000-02-28 Wisconsin Alumni Research Foundation Method of reducing retinal ganglion cell degeneration
JP4000505B2 (ja) * 1999-12-01 2007-10-31 第一三共株式会社 緑内障を治療するための併用剤
AU2003280812A1 (en) * 2002-11-18 2004-06-15 Santen Pharmaceutical Co., Ltd. REMEDY FOR GLAUCOMA COMPRISING Rho KINASE INHIBITOR AND Beta-BLOCKER
WO2015031109A1 (en) * 2013-08-28 2015-03-05 University Of Pittsburgh-Of The Common Wealth System Of Higher Education Inhibition of wnt, tgf beta and hippo signaling pathways to treat cancer, organ fibrosis and metabolic disorders
AU2017382176A1 (en) 2016-12-21 2019-05-30 Biotheryx, Inc. Thienopyrrole derivatives for use in targeting proteins, compositions, methods, and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3655663A (en) * 1969-04-21 1972-04-11 Burton K Wasson 4-(3-secondary amino-2-hydroxy-proxy) 1 2 5-thiadiazoles
US4911920A (en) * 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy
DE3568431D1 (en) * 1984-12-12 1989-04-06 Merck & Co Inc Substituted aromatic sulfonamides, their preparation and ophthalmic compositions containing them
US4797413A (en) * 1986-05-14 1989-01-10 Merck & Co., Inc. Thieno thiopyran sulfonamide derivatives, pharmaceutical compositions and use
US4863922A (en) * 1984-12-12 1989-09-05 Merck & Co., Inc. Substituted aromatic sulfonamides as antiglaucoma agents, compositions and use
US4731368A (en) * 1986-12-08 1988-03-15 Merck & Co., Inc. Thienopyridine sulfonamides and their ophthalmological formulation
US4751231A (en) * 1987-09-16 1988-06-14 Merck & Co., Inc. Substituted thieno[2,3-b]pyrrole-5-sulfonamides as antiglaucoma agents
EP0309028A3 (en) * 1987-09-16 1990-06-27 Merck & Co. Inc. Substituted thieno(2,3-b)furan-2-sulfonamides as antiglaucoma agents
US4946859A (en) * 1989-07-31 1990-08-07 Merck & Co., Inc. 4-(2-methyl-2-hydroxypropylamino)-5,6-dihydrothieno-[2,3-b]thiopyran-2-sulfonamide-7,7-dioxide
US5153192A (en) 1990-04-09 1992-10-06 Alcon Laboratories, Inc. Thiophene sulfonamides useful as carbonic anhydrase inhibitors
IE911192A1 (en) * 1990-04-12 1991-10-23 Merck & Co Inc Substituted aromatic sulfonamides as antiglaucoma agents
DK0495421T3 (da) * 1991-01-15 1996-12-09 Alcon Lab Inc Anvendelse af carragenaner i topiske ophthalmiske sammensætninger
JP2536806B2 (ja) * 1991-03-27 1996-09-25 アルコン ラボラトリーズ インコーポレイテッド ゲル化多糖類と微粉砕された薬剤担体とを組み合わせた局部眼科用組成物
IL101537A (en) * 1991-04-17 1997-11-20 Merck & Co Inc OPHTHALMIC COMPOSITIONS COMPRISING COMBINATIONS OF A CARBONIC ANHYDRASE INHIBITOR AND A b-ADRENERGIC ANTAGONIST

Also Published As

Publication number Publication date
WO1993016701A3 (en) 1994-01-06
AU677577B2 (en) 1997-05-01
JPH07504899A (ja) 1995-06-01
EP0625903A1 (en) 1994-11-30
JPH10324640A (ja) 1998-12-08
ES2118941T3 (es) 1998-10-01
DE69320329D1 (de) 1998-09-17
CA2129037C (en) 1998-03-24
HK1009941A1 (en) 1999-06-11
DE69320329T2 (de) 1998-12-24
AU3725793A (en) 1993-09-13
EP0625903B1 (en) 1998-08-12
CA2129037A1 (en) 1993-09-02
JP2965267B2 (ja) 1999-10-18
WO1993016701A2 (en) 1993-09-02
ATE169499T1 (de) 1998-08-15

Similar Documents

Publication Publication Date Title
AU1387088A (en) Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocularpressure
EP0308021A3 (en) Subsituted thieno (2,3-b)pyrole-5-sulfonamides as antiglaucoma agents
CA2080223A1 (en) Thiophene sulfonamides useful as carbonic anhydrase inhibitors
FI902258A0 (fi) Menetelmä farmakologisesti aktiivisten 13,14-dihydro-17-fenyyli-18,19,20-trinor-PGF2 -alkyyliestereiden valmistamiseksi
AU6877994A (en) Use of cloprostenol, fluprostenol and their analogues to treat glaucoma and ocular hypertension
NZ234143A (en) Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
CA2021316A1 (en) Intraocular pressure reducing 11-acyl prostaglandins
IE811654L (en) Ophthalmic composition
CA2126086A1 (en) Imidazoylalkyl Substituted with a Six Membered Nitrogen Containing Heterocyclic Ring
WO1993016701A3 (en) Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers
RU94041703A (ru) Аэрозольные упаковки под давлением и способ их получения
ATE223200T1 (de) Einen carboanhydrase-hemmer und xanthangummi enthaltendes augenarzneimittel
AU1745388A (en) Thiophene sulfonamide antiglaucoma agents
WO1992000287A3 (en) Analogs of carbonic anhydrase inhibitors and their use as topical iop inhibitors
EP0036351A3 (en) Ophthalmic compositions of carbonic anhydrase inhibitors for topical application in the treatment of elevated intraocular pressure
BR9307099A (pt) Formulação de colírio processo para preparar uma formulação de colírio e processo de tratamento de hipertensão ocular e glaucoma
AU687906B2 (en) Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
KR880001290A (ko) β-차단제 및 필로카르핀-함유 제제
NO924549L (no) Fremgangsmaate for fremstilling av vandig suspensjon
KR950702422A (ko) (에스)-티몰롤 헤미하이드레이트를 함유하는 안약 국소 조성물(ophthalmic topical composition containing (s)-timolol hemihydrate)
ATE98647T1 (de) Substituierte thieno(2,3-b) thiophen-2sulfonamide als mittel gegen glaukoma.
RU97116792A (ru) Способ лечения эрозий роговицы после эксимерлазерной фоторефракционной кератэктомии
RU95109145A (ru) Офтальмологический препарат, способ его получения, применение препарата для лечения гипертензии и глаукомы
NO177705C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive ascorbinsyrederivater
EP0309028A3 (en) Substituted thieno(2,3-b)furan-2-sulfonamides as antiglaucoma agents